News
Antengene to collaborate with LegoChem Biosciences for antibody-drug conjugates
Antengene, a clinical stage biopharmaceutical company, is to enter into a Research Collaboration and License Option Agreement with LegoChem Biosciences (LCB), for new antibody-drug conjugates (ADCs).